$1,000 follows their calls into $956
rahmbo@rahmbotradesBetter late than never $FRMI SIGNS CREDIT SUPPORT AGREEMENT WITH $AMD AND ANNOUNCES PARTNERSHIP $FRMI is a $10 stock disguised as $4 right now
Fermi America@FermiAmericaWe’ve signed a credit support agreement with @AMD and a framework for future expansion. $FRMI
rahmbo@rahmbotradesAs a near:native bull, I'm not surprised at the strength in the token today If you haven't tried creating an account on NEAR, I really recommend it I also think this is a very good opportunity for $SVRN Not only is $SVRN holding 55.5M near:native tokens, but they're also
rahmbo@rahmbotradesI actually think that Anthropic just cooked $GTLB, and today's selloff should've been a lot worse Anthropic announced that they built their own version control system in-house over the past five months, and they are calling it "Scion" They built it because Claude was generating
rahmbo@rahmbotradesThe $GTLB CEO issued a formal response to Anthropic's article yesterday, and I still don't understand how you can spin this as bullish for $GTLB 1) Their entire rebuttal is simply addressing the problem and saying "we're working on a solution." That's great, but my biggest
rahmbo@rahmbotradesSo, basically git became a bottleneck at Anthropic this year because it couldn't handle agent-scale output And apparently $GTLB has been working on solutions for these exact challenges with Anthropic as a design partner? But when git became a serious bottleneck this year,
rahmbo@rahmbotradesFDA peptide policy is now at OMB...which means it's probably published by late November (that's not official, that's just how these reviews usually go) Oh and I recently bought finasteride, so I had to take some $HIMS calls
Hims House@himshouse$HIMS 🚨 BREAKING: HUGE NEWS FOR PEPTIDES!! THE FDA HAS OFFICIALLY SUBMITTED AN INTERIM ACCESS POLICY FOR COMPOUNDED PEPTIDES FOR FEDERAL REVIEW THIS WOULD OPEN THE DOOR TO LEGAL NATIONWIDE ACCESS TO CERTAIN PEPTIDES PENDING APPROVAL
